Comments
Bristol-Myers drug fails liver cancer trial
20.07.2012. | (Reuters) - Bristol-Myers Squibb Co on Thursday said its experimental drug brivanib failed in a late-stage trial to match Nexavar, a cancer treatment sold by Bayer AG and Onyx Pharmaceuticals Inc, in prolonging the lives of patients with advanced liver cancer...
